Author Correction: Codon-specific translation reprogramming promotes resistance to targeted therapy

被引：0
|
作者：
Francesca Rapino
Sylvain Delaunay
Florian Rambow
Zhaoli Zhou
Lars Tharun
Pascal De Tullio
Olga Sin
Kateryna Shostak
Sebastian Schmitz
Jolanda Piepers
Bart Ghesquière
Latifa Karim
Benoit Charloteaux
Diane Jamart
Alexandra Florin
Charles Lambert
Andrée Rorive
Guy Jerusalem
Eleonora Leucci
Michael Dewaele
Marc Vooijs
Sebastian A. Leidel
Michel Georges
Marianne Voz
Bernard Peers
Reinhard Büttner
Jean-Christophe Marine
Alain Chariot
Pierre Close
机构：
[1] University of Liège,Laboratory of Cancer Signaling
[2] University of Liège,GIGA
[3] KU Leuven,institute
[4] Center for Cancer Biology,Laboratory for Molecular Cancer Biology, Department of Oncology
[5] VIB,Institute for Pathology
[6] University Hospital Cologne,Centre for Interdisciplinary Research on Medicines (CIRM)
[7] University of Liège,Faculty of Medicine
[8] Max Planck Research Group for RNA Biology,Cells
[9] Max Planck Institute for Molecular Biomedicine,in
[10] University of Münster,Motion Cluster of Excellence
[11] University of Münster,Laboratory of Medical Chemistry
[12] University of Liège,Department of Radiotherapy (MAASTRO)/GROW, School for Developmental Biology and Oncology
[13] Maastricht University,Metabolomics Core Facility
[14] Center for Cancer Biology,Unit of Animal Genomics
[15] VIB,Medical Oncology, CHU Sart Tilman Liège
[16] University of Liège,undefined
[17] University of Liège,undefined
[18] WELBIO,undefined
[19] University of Liège,undefined
来源：
Nature | 2021年 / 599卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：E14 / E14
相关论文
共 50 条
  • [41] Gene Correction of LGMD2A Patient-Specific iPS Cells for Targeted Autologous Cell Therapy
    Selvaraj, Sridhar
    Filareto, Antonio
    Kiley, James
    Voytas, Daniel
    Kyba, Michael
    Perlingeiro, Rita
    MOLECULAR THERAPY, 2016, 24 : S125 - S126
  • [42] Gene Correction of LGMD2A Patient-Specific iPSCs for the Development of Targeted Autologous Cell Therapy
    Selvaraj, Sridhar
    Dhoke, Neha R.
    Kiley, James
    Mateos-Aierdi, Alba Judith
    Tungtur, Sudheer
    Mondragon-Gonzalez, Ricardo
    Killeen, Grace
    Oliveira, Vanessa K. P.
    de Munain, Adolfo Lopez
    Perlingeiro, Rita C. R.
    MOLECULAR THERAPY, 2019, 27 (12) : 2147 - 2157
  • [43] Towards targeted prescribing: will the cure for antimicrobial resistance be specific, directed therapy through improved diagnostic testing?
    Peterson, LR
    Dalhoff, A
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (06) : 902 - 905
  • [44] Targeted skipping of a single exon harboring a premature termination codon mutation: Implications and potential for gene correction therapy for selective dystrophic epidermolysis bullosa patients
    Goto, Maki
    Sawamura, Daisuke
    Nishie, Wataru
    Sakai, Kaori
    McMillan, James R.
    Akiyama, Masashi
    Shimizu, Hiroshi
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (12) : 2614 - 2620
  • [45] FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor
    Sun, Qian
    Novak, Daniel
    Hueser, Laura
    Poelchen, Juliane
    Wu, Huizi
    Granados, Karol
    Federico, Aniello
    Liu, Ke
    Steinfass, Tamara
    Vierthaler, Marlene
    Umansky, Viktor
    Utikal, Jochen
    INTERNATIONAL JOURNAL OF CANCER, 2021, 149 (03) : 657 - 674
  • [46] SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma
    Hueser, Laura
    Sachindra, Sachindra
    Granados, Karol
    Federico, Aniello
    Larribere, Lionel
    Novak, Daniel
    Umansky, Viktor
    Altevogt, Peter
    Utikal, Jochen
    INTERNATIONAL JOURNAL OF CANCER, 2018, 143 (12) : 3131 - 3142
  • [47] ENPP1 promotes immune suppression, drug resistance, and adverse outcomes in bladder cancer: Potential for targeted therapy
    You, Chengyu
    Fang, Qixiang
    Xiao, Xi
    Liu, Yang
    Yang, Weiguang
    Qing, Liangliang
    Li, Qingchao
    Li, Rongxin
    Wang, Yanan
    Dong, Zhilong
    CANCER GENETICS, 2025, 294 : 1 - 14
  • [48] FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor
    Sun, Qian
    Novak, Daniel
    Huser, Laura
    Poelchen, Juliane
    Wu, Huizi
    Granados, Karol
    Federico, Aniello Federico
    Liu, Ke
    Steinfass, Tamara
    Vierthaler, Marlene
    Umansky, Viktor
    Utikal, Jochen
    CANCER RESEARCH, 2023, 83 (07)
  • [49] Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation
    Zhang, Zeda
    Zhou, Chuanli
    Li, Xiaoling
    Barnes, Spencer D.
    Deng, Su
    Hoover, Elizabeth
    Chen, Chi-Chao
    Lee, Young Sun
    Zhang, Yanxiao
    Wang, Choushi
    Metang, Lauren A.
    Wu, Chao
    Tirado, Carla Rodriguez
    Johnson, Nickolas A.
    Wongvipat, John
    Navrazhina, Kristina
    Cao, Zhen
    Choi, Danielle
    Huang, Chun-Hao
    Linton, Eliot
    Chen, Xiaoping
    Liang, Yupu
    Mason, Christopher E.
    de Stanchina, Elisa
    Abida, Wassim
    Lujambio, Amaia
    Li, Sheng
    Lowe, Scott W.
    Mendell, Joshua T.
    Malladi, Venkat S.
    Sawyers, Charles L.
    Mu, Ping
    CANCER CELL, 2020, 37 (04) : 584 - +
  • [50] Author Correction: Engineered bioorthogonal POLY-PROTAC nanoparticles for tumour-specific protein degradation and precise cancer therapy
    Jing Gao
    Bo Hou
    Qiwen Zhu
    Lei Yang
    Xingyu Jiang
    Zhifeng Zou
    Xutong Li
    Tianfeng Xu
    Mingyue Zheng
    Yi-Hung Chen
    Zhiai Xu
    Huixiong Xu
    Haijun Yu
    Nature Communications, 13
12345